title: Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis.
authors.affiliation: Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Onozawa
authors.forename: Satoshi
authors.initials: S
authors.lastname: Hashino
authors.forename: Susumu
authors.initials: S
authors.lastname: Sogabe
authors.forename: Masahira
authors.initials: M
authors.lastname: Haneda
authors.forename: Hiromasa
authors.initials: H
authors.lastname: Horimoto
authors.forename: Koh
authors.initials: K
authors.lastname: Izumiyama
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kondo
authors.forename: Luis Perez
authors.initials: LP
authors.lastname: Aldana
authors.forename: Kunio
authors.initials: K
authors.lastname: Hamada
authors.forename: Masahiro
authors.initials: M
authors.lastname: Asaka
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D013792:Thalidomide